Tyme Technologies, Inc(NASDAQ:TYME) 
Tyme Technologies, Inc., a clinical-stage biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States. Its lead candidate is the SM-88, a CMBT that is in a Phase II/III clinical trial to treat across 15 types of cancer, including pancreatic, lung, breast, prostate,...
Website: http://www.tymetechnologiesinc.com
Full Time Employees: 18 (May 2021)
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2022-03-21
P
O 0.34
H 0.34
L 0.33
C 0.33
V 263,797
10EMA 0.33
20EMA 0.33
60EMA 0.33
120EMA 0.33
250EMA 0.33